Last updated on February 2019

Post-marketing Surveillance Study of Adalimumab (Humira ) for Non-infectious Intermediate Posterior or Panuveitis Patients


Brief description of study

The objective of this study is to evaluate the safety and effectiveness of Humira (Adalimumab) for the treatment of non-infectious intermediate, posterior, or panuveitis patients under a routine treatment practice.

Clinical Study Identifier: NCT03339102

Find a site near you

Start Over